Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:28 AM
Ignite Modification Date:
2025-12-25 @ 4:28 AM
NCT ID:
NCT04611620
Eligibility Criteria:
Inclusion Criteria:
Inclusion Criteria for Breast cancer survivors:
1. Female BCS
2. ≥ 21 years of age and older
3. Ability to provide written consent and HIPAA authorization
4. ≥6 months post-adjuvant therapy and neo-adjuvant therapy for early stage (Stage I-IIIA) breast cancer.
Current Aromatase Inhibitors or Tamoxifen treatment at time of enrollment is allowed.
5. Identify cognitive concerns (select yes)
Inclusion Criteria for Colorectal cancer survivors:
1. Male or female CRC survivors
2. Ability to provide written consent and HIPAA authorization
3. ≥ 21 years of age and older
4. ≥6 months post-adjuvant therapy and neo-adjuvant therapy for early stage (stage I-III) CRC
5. Identify cognitive concerns (select yes)
Exclusion Criteria:
1. Report metastatic breast or colorectal cancer (Stage IV) at time of consenting.
2. Unable to read and understand English to complete survey questionnaires.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
21 Years
Study:
NCT04611620
Study Brief:
Protocol Section:
NCT04611620